1,720,961 research outputs found
ORGANIZACIJSKO USTROJSTVO BEZIRKA SPANDAU U NJEMAČKOM GLAVNOM GRADU BERLINU
No full textU završnom radu se objašnjava organizacijsko ustrojstvo Bezirka Spandau u
njemačkom glavnom gradu Berlinu. Savezna Republika Njemačka je federalna država
sastavljena od 13 saveznih zemalja (Länder) i tri grada koja imaju i status saveznih zemalja
(Berlin, Hamburg, Bremen). Okrug Spandau je najstarija četvrt u Berlinu koja je povijesno
rasla. Četvrta najveća četvrt u Berlinu nudi razne povijesne spomenike i znamenitosti.
Spandau je bogat tradicijom i najveća je berlinska industrijska lokacija. Rad okruga Spandau
je vrlo uspješan u suradnji između različitih lokalnih aktera iz politike, uprave, gospodarstva i
socijalnog partnerstva temelj je ovog saveza. Zajednički cilj je poboljšati stanje zaposlenosti i
kvalitete života u okrugu te ojačati lokalnu gospodarsku snagu
ORGANIZACIJSKO USTROJSTVO BEZIRKA SPANDAU U NJEMAČKOM GLAVNOM GRADU BERLINU
No full textU završnom radu se objašnjava organizacijsko ustrojstvo Bezirka Spandau u
njemačkom glavnom gradu Berlinu. Savezna Republika Njemačka je federalna država
sastavljena od 13 saveznih zemalja (Länder) i tri grada koja imaju i status saveznih zemalja
(Berlin, Hamburg, Bremen). Okrug Spandau je najstarija četvrt u Berlinu koja je povijesno
rasla. Četvrta najveća četvrt u Berlinu nudi razne povijesne spomenike i znamenitosti.
Spandau je bogat tradicijom i najveća je berlinska industrijska lokacija. Rad okruga Spandau
je vrlo uspješan u suradnji između različitih lokalnih aktera iz politike, uprave, gospodarstva i
socijalnog partnerstva temelj je ovog saveza. Zajednički cilj je poboljšati stanje zaposlenosti i
kvalitete života u okrugu te ojačati lokalnu gospodarsku snagu
COMBINED INTRAVITREAL BEVACIZUMAB AND TRIAMCINOLONE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION
No full textABSTRACT.
Purpose: We report on thè combined application of intravitreal bevacizumab
and triamcinolone acetonide for treatment of exudative age-related macular
degeneration (AMD).
Methods: The clinical interventional case-series study included 16 patients (16
eyes) with exudative AMD who had previously received 3.5 ±1. 8 mono-injec-tions of bevacizumab (1.5 mg) without significant improvement in visual acuity
(VA) or reduction in macular exudation. AH patients underwent a combined
intravitreal injection of bevacizumab (1.5 mg) and triamcinolone acetonide
(about 20 mg). Main outcome measures were VA and macular thickness as
determined by optical coherence tomography. AH patients were re-examined at
2-3 months after thè intervention.
Results: Visual acuity improved significantly (p = 0.03) from 0.80 ± 0.40
logMAR prior to thè combined injection to 0.65 ± 0.42 logMAR at 3 months
after thè injection. An improvement of > 1 Snellen line was found in eight sub-jects, an increase of > 2 lines in five subjects, and an improvement of > 3 lines
in two subjects. One patient lost 1 line and one patient lost 3 lines. Central
retinal thickness decreased significantly from 272 ± 62 ^m to 220 ± 47 firn
(p = 0.03). At thè 6-month follow-up examination, centrai retinal thickness
had increased again to 319 ± 142 fan, which was not significantly (p = 0.30)
different from baseline measurements.
Conclusions: The combined intravitreal application of bevacizumab and triam-cinolone may temporarily be helpful in thè treatment of exudative AMD if
previous intravitreal bevacizumab mono-injections bave failed to improve vision
and reduce macular oedema
INRAVITREAL BEVACIZUMAB COMBINED WITH CATARACT SURGERY FOR TREATMENT OF EXUDATIVE MACULAR DEGENERATION
No full textPURPOSE: The aim of this study was to report on the combination of an intravitreal injection of bevacizumab and cataract surgery in patients with exudative age-related macular degeneration (AMD). METHODS: The interventional case series study included 11 patients (11 eyes) who received an intravitreal injection of 1.5 mg bevacizumab as treatment of exudative AMD (n = 10) or exudative myopic macular degeneration (n = 1), combined with a routine phacoemulsification and posterior chamber lens implantation for treatment of cataract. RESULTS: Intraoperatively and during the follow-up of 150 +/- 77.5 days, there were no complications related to the intravitreal application of bevacizumab combined with cataract surgery, such as wound dehiscence and leakage, delayed wound healing, corneal edema, dislocation of the pseudophakos, rupture of the posterior lens capsule, or rhegmatogenous retinal detachment. CONCLUSIONS: The results of this pilot study suggest that from a safety point of view, intravitreal injections of bevacizumab may be combined with routine cataract surgery
Visual acuity change after intravitreal bevacizumab for exudative age-related macular degeneration in relation to subfoveal membrane type
No full textPurpose: To examine an association between the subfoveal neovascular membrane type and visual acuity change after intravitreal bevacizumab injection for exudative age-related macular degeneration (AMD). Methods: We carried out a clinical, retrospective, interventional case-series study including 66 consecutive patients (67 eyes) with exudative AMD who received an intravitreal injection of 1.5 mg bevacizumab. Study subgroups included the occult type without or with minimally classic subfoveal neovascularization (n = 28 eyes, 42%), predominantly or purely classic subfoveal neovascularization (n = 22 eyes, 33%), and eyes with retinal pigment epithelium detachment (n = 17 eyes, 25%). Follow-up was ≥ 2 months. Results: The maximal visual acuity (VA) gain (mean ± standard deviation - 0.07 ± 0.30 logMAR, 0.5 ± 2.9 Snellen lines; p = 0.87), and VA gain at 1 month (p = 0.10), 2 months (p = 0.77) and 3 months (p = 0.35) after the injection did not vary significantly between the three study subgroups. Correspondingly, a multivariate analysis did not reveal a statistically significant (p = 0.57) influence of subfoveal lesion type on gain in VA. Conclusions: Visual improvement after intravitreal bevacizumab does not differ markedly between various types of subfoveal neovascularization in AMD. © 2007 The Authors Journal compilation 2007 Acta Ophthalmol Scand
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Variations on the Author
Full text link“Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship
Appropriate Similarity Measures for Author Cocitation Analysis
Full text linkWe provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Dispelling the Myths Behind First-author Citation Counts
Full text linkWe conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued
use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation
counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more
sophisticated methods
- …
